ONTO Stock Analysis: Onto Innovation | NYSE
Semiconductor Equipment & Materials | NYSE, USA | Market Cap: 18.306m USD | 12M Return: 161.2% | US6833441057 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 349M
EPS Trend: 72.8%
Qual. Beats: 1
Rev. Trend: 92.8%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Onto Innovation Inc. (NYSE: ONTO) designs, manufactures, and supports process control tools used for macro-defect inspection and metrology across the semiconductor and advanced packaging industries. Its product portfolio includes lithography systems, automated metrology systems, wafer all-surface inspection, defect classification and pattern analysis, yield management software, and thin film measurement tools, serving customers in the United States, Taiwan, South Korea, Japan, China, Southeast Asia, and Europe. The companys tools are used by semiconductor and advanced packaging manufacturers, silicon wafer producers, LED and VCSEL makers, MEMS and CMOS image sensor fabs, power and RF device makers, and data storage producers. Headquartered in Wilmington, Massachusetts, the company was founded in 1940 and is listed within the GICS Semiconductor Materials & Equipment sub-industry. As a large-cap Information Technology stock with a market capitalization of roughly $16 billion, Onto Innovation operates within a sector characterized by high R&D intensity, long product cycles, and close customer integration with leading-edge fabs.
- HBM and AI chip demand accelerates advanced packaging lithography orders
- Memory capex recovery lifts metrology and inspection tool revenue
- China revenue faces escalating US semiconductor export control restrictions
| Net Income: 132.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -4.78 > 1.0 |
| NWC/Revenue: 211.6% < 20% (prev 129.2%; Δ 82.44% < -1%) |
| CFO/TA 0.07 > 3% & CFO 266.2m > Net Income 132.6m |
| Net Debt (-392.9m) to EBITDA (264.7m): -1.48 < 3 |
| Current Ratio: 9.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.7m) vs 12m ago 1.36% < -2% |
| Gross Margin: 50.36% > 18% (prev 51.54%; Δ -1.18% > 0.5%) |
| Asset Turnover: 38.37% > 50% (prev 48.42%; Δ -10.06% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.64 (Total Current Assets 2.64b - Total Current Liabilities 271.6m) / Total Assets 3.70b |
| B: 0.23 (Retained Earnings 837.6m / Total Assets 3.70b) |
| C: 0.05 (EBIT TTM 158.1m / Avg Total Assets 2.92b) |
| D: 1.08 (Book Value of Equity 1.92b / Total Liabilities 1.78b) |
| Altman-Z'' = 6.44 = AAA |
| DSRI: 1.09 (Receivables 337.4m/285.3m, Revenue 1.12b/1.04b) |
| GMI: 1.02 (GM 51.54% / 50.36%) |
| AQI: 1.08 (AQ_t 0.25 / AQ_t-1 0.23) |
| SGI: 1.08 (Revenue 1.12b / 1.04b) |
| TATA: -0.04 (NI 132.6m - CFO 266.2m) / TA 3.70b) |
| Beneish M = -2.83 (Cap -4..+1) = A |
As of August 25, 2026, the stock is trading at USD 282.91 with a total of 713,793 shares traded. Over the past week, the price has changed by -19.44%, over one month by +3.77%, over three months by +3.19% and over the past year by +161.18%.
Current recommended Stop Loss: 247.40 (which is 12.6% or 1.4 ATR below the current price).
Onto Innovation has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy ONTO.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 388.5 | 37.3% |
P/E Trailing = 117.451
P/E Forward = 39.2157
P/S = 16.3431
P/B = 8.0508
P/EG = 1.3053
Revenue TTM = 1.12b USD
EBIT TTM = 158.1m USD
EBITDA TTM = 264.7m USD
Long Term Debt = 1.47b USD (from longTermDebt, last quarter)
Short Term Debt = 6.22m USD (from shortTermDebt, last fiscal year)
Debt = 1.49b USD (from shortLongTermDebtTotal, last quarter) + Leases 17.5m
Net Debt = -392.9m USD (calculated: Debt 1.49b - CCE 1.88b)
Enterprise Value = 17.9b USD (18.3b + Debt 1.49b - CCE 1.88b)
Interest Coverage Ratio = unknown (Ebit TTM 158.1m / Interest Expense TTM 0.0)
EV/FCF = 77.80x (Enterprise Value 17.9b / FCF TTM 230.2m)
FCF Yield = 1.29% (FCF TTM 230.2m / Enterprise Value 17.9b)
FCF Margin = 20.55% (FCF TTM 230.2m / Revenue TTM 1.12b)
Net Margin = 11.84% (Net Income TTM 132.6m / Revenue TTM 1.12b)
Gross Margin = 50.36% ((Revenue TTM 1.12b - Cost of Revenue TTM 556.1m) / Revenue TTM)
Gross Margin QoQ = 53.41% (prev 50.14%)
Tobins Q-Ratio = 4.84 (Enterprise Value 17.9b / Total Assets 3.70b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 1.49b)
Taxrate = 16.10% (25.4m / 158.1m)
NOPAT = 132.6m (EBIT 158.1m * (1 - 16.10%))
Current Ratio = 6.43 (Total Current Assets 2.64b / Total Current Liabilities 411.1m)
Debt / Equity = 0.77 (Debt 1.49b / totalStockholderEquity, last quarter 1.92b)
Debt / EBITDA = -1.48 (Net Debt -392.9m / EBITDA 264.7m)
Debt / FCF = -1.71 (Net Debt -392.9m / FCF TTM 230.2m)
Total Stockholder Equity = 2.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.54% (Net Income 132.6m / Total Assets 3.70b)
RoE = 6.50% (Net Income TTM 132.6m / Total Stockholder Equity 2.04b)
RoCE = 4.50% (EBIT 158.1m / Capital Employed (Equity 2.04b + L.T.Debt 1.47b))
RoIC = 3.93% (NOPAT 132.6m / Invested Capital 3.38b)
WACC = 13.26% (E(18.3b)/V(19.8b) * Re(14.34%) + D(1.49b)/V(19.8b) * Rd(0.0%) * (1-Tc(0.16)))
Discount Rate = 14.34% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -0.21 | Cagr: 0.04%
[DCF] Terminal Value 59.84% ; FCFF base≈232.4m ; Y1≈228.9m ; Y5≈233.4m
[DCF] Fair Price = 39.05 (EV 1.99b - Net Debt -392.9m = Equity 2.39b / Shares 61.1m; r=13.26% [WACC]; 5y FCF grow -2.26% → 2.50% )
EPS Correlation: 72.76 | EPS CAGR: 11.74% | SUE: 4.0 | # QB: 1
Revenue Correlation: 92.77 | Revenue CAGR: 10.63% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-09-30): EPS=2.30 | Chg30d=+19.08% | Revisions=+75% | Analysts=11
EPS current Year (2026-12-31): EPS=8.10 | Chg30d=+12.62% | Revisions=+75% | GrowthEPS=+64.0% | GrowthRev=+43.0%
EPS next Year (2027-12-31): EPS=11.65 | Chg30d=+17.19% | Revisions=+75% | GrowthEPS=+43.8% | GrowthRev=+30.0%
[Analyst] Revisions Ratio: +90% (up=27, down=0)